1. Medtech Insight
  2. >>Device Area
  3. >>Cardiology

SCAI2018: New Study Shows 3D Printing Helps Prevent Leaks In Heart-Valve Patients

 
• By Marion Webb

The clinical use of 3D printing got a boost when interventional cardiologists presented data at the annual meeting of The Society for Cardiovascular Angiography and Interventions that supported th4 technology's effectiveness in helping to predict paravalvular leak in patients undergoing transcatheter aortic valve replacement. The implantation of an ill-fitting valve that can lead to paravalvular leak is a common risk of TAVR procedures.

Two female hands holding a 3d printed human heart

Data from a new study that evaluated the effectiveness of 3D printing and computer modeling in predicting paravalvular leak (PVL) in patients undergoing transcatheter aortic valve replacement (TAVR) has backed the use of the technology for addressing the problem of ill-fitting valves. The data was presented on April 26 at the 41st annual Society for Cardiovascular Angiography and Interventions (SCAI) meeting, which is being held in San Diego through April 28. 

In the study, six patients undergoing TAVR for severe calcific aortic stenosis and at risk for PVL had pre-procedure computed tomography (CT) images analyzed and segmented for printing of 3D models

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cardiology

More from Device Area

Consumer Healthtech Investment Totaled $4.5BN In 2024, But Bar Is High Amid Economic Uncertainty

 
• By Marion Webb

Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.

FDA And Boston Scientific Face Legal Action Over Spinal Device Safety

 
• By Elizabeth Orr

A patient, Dena Lawler, is suing Boston Scientific and the US FDA over alleged harm from a spinal stimulator device. Lawler claims inadequate regulatory review allowed dangerous modifications to the device, which then caused her pain and other health issues. She is calling for reconsideration of the device approvals.

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 
• By Brian Bossetta

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.